Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Advanced Cancer × Fluoxetine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

Standard of Care 6 Surveys and Questionnaires 2 Interviews as Topic 2 zaleplon 1 olanzapine-fluoxetine combination 1 Videotape Recording 1 Rehabilitation 1 Referral and Consultation 1 Olanzapine 1 Neoadjuvant Therapy 1 Health Services Needs and Demand 1 Fluoxetine 1 Decision Support Techniques 1 Counseling 1 Control Groups 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00512291 2011-09-27

Subcutaneous Olanzapine for Hyperactive or Mixed Delirium

M.D. Anderson Cancer Center

Phase NA Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡